Review: Troponin has prognostic value in CKD without ACS

August 12, 2014
Review: troponin has prognostic value in CKD without ACS

(HealthDay)—For patients with chronic kidney disease (CKD) without suspected acute coronary syndrome (ACS), troponin levels may have prognostic and diagnostic value, according to two reviews published online Aug. 12 in the Annals of Internal Medicine.

Erin D. Michos, M.D., M.H.S., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues conducted a of 98 observational studies to examine the prognostic value of troponin for patients with CKD without ACS. The researchers found that, among patients receiving dialysis, elevated correlated with all-cause and cardiovascular mortality. After adjustment for age and coronary artery disease or a risk equivalent, the pooled hazard ratios for all-cause and were 3.0 and 3.3, respectively, for elevated troponin T and 2.7 and 4.2, respectively, for elevated troponin I.

Sylvie R. Stacy, M.D., M.P.H., from the Johns Hopkins University Bloomberg School of Public Health in Baltimore, and colleagues conducted a systematic review involving 23 studies to assess the utility of troponin in ACS diagnosis in patients with CKD with suspected ACS. The researchers found that, for ACS diagnosis, the sensitivity and specificity of troponin T ranged from 71 to 100 percent and from 31 to 86 percent, respectively. For troponin I, the sensitivity and specificity ranged from 43 to 94 percent and from 48 to 100 percent, respectively. Elevated troponin I or troponin T levels correlated with increased risk of short-term death and cardiac events.

"Researchers should continue to try to determine optimal cut points for troponin levels in various patient populations and test management strategies based on these levels," write the authors of an accompanying editorial.

Explore further: Elevated glucose associated with undetected heart damage

More information: Abstract - Michos
Full Text
Abstract - Stacy
Full Text
Editorial (subscription or payment may be required)

Related Stories

Elevated glucose associated with undetected heart damage

February 2, 2012
A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health suggests that hyperglycemia (high blood sugar) injures the heart, even in patients without a history of heart disease or diabetes. Researchers ...

Efforts to cut unnecessary blood testing bring major decreases in health care spending

July 1, 2014
Researchers at Johns Hopkins Bayview Medical Center used two relatively simple tactics to significantly reduce the number of unnecessary blood tests to assess symptoms of heart attack and chest pain and to achieve a large ...

Risk of death up for PE patients with high plasma lactate levels

January 24, 2013
(HealthDay)—Adult patients with acute pulmonary embolism (PE) with elevated plasma lactate levels are at a high risk of death and adverse outcomes, regardless of whether they also present with shock or hypotension; right-sided ...

Mortality up with CKD in PCI contrast-induced nephropathy

August 7, 2014
(HealthDay)—Contrast-induced nephropathy (CIN) is associated with long-term mortality in patients with, but not those without, chronic kidney disease (CKD), according to a study published in the Aug. 1 issue of The American ...

Tests for biomarker may help determine diagnosis of heart attack within hours

December 27, 2011
For patients admitted to an emergency department with chest pain, use of a contemporary or highly sensitive test for levels of troponin I (a protein in muscle tissue) may help rule-out a diagnosis of heart attack, while changes ...

Recommended for you

A nanoparticle inhalant for treating heart disease

January 18, 2018
A team of researchers from Italy and Germany has developed a nanoparticle inhalant for treating people suffering from heart disease. In their paper published in the journal Science Translational Medicine, the group describes ...

Starting periods before age of 12 linked to heightened risk of heart disease and stroke

January 15, 2018
Starting periods early—before the age of 12—is linked to a heightened risk of heart disease and stroke in later life, suggests an analysis of data from the UK Biobank study, published online in the journal Heart.

'Decorated' stem cells could offer targeted heart repair

January 10, 2018
Although cardiac stem cell therapy is a promising treatment for heart attack patients, directing the cells to the site of an injury - and getting them to stay there - remains challenging. In a new pilot study using an animal ...

Two simple tests could help to pinpoint cause of stroke

January 10, 2018
Detecting the cause of the deadliest form of stroke could be improved by a simple blood test added alongside a routine brain scan, research suggests.

Exercise is good for the heart, high blood pressure is bad—researchers find out why

January 10, 2018
When the heart is put under stress during exercise, it is considered healthy. Yet stress due to high blood pressure is bad for the heart. Why? And is this always the case? Researchers of the German Centre for Cardiovascular ...

Heart-muscle patches made with human cells improve heart attack recovery

January 10, 2018
Large, human cardiac-muscle patches created in the lab have been tested, for the first time, on large animals in a heart attack model. This clinically relevant approach showed that the patches significantly improved recovery ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.